Cholangiocarcinoma risk factors: Difference between revisions
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) |
||
| Line 38: | Line 38: | ||
**Opisthorchis viverrini | **Opisthorchis viverrini | ||
**Clonorchis sinensis | **Clonorchis sinensis | ||
**Caroli's disease | |||
**Inherited disorders | **Inherited disorders | ||
***Lynch syndrome | ***Lynch syndrome | ||
Revision as of 15:36, 24 January 2018
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangiocarcinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Cholangiocarcinoma risk factors |
|
Risk calculators and risk factors for Cholangiocarcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Suveenkrishna Pothuru, M.B,B.S. [3]
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
- Common risk factors in the development of cholangiocarcinoma include primary sclerosing cholangitis, fibropolycystic liver disease such as choledochal cysts, hepatolithiasis and recurrent pyogenic cholangitis.
Common Risk Factors
- Common risk factors in the development of cholangiocarcinoma include:[1][2][3][4][5]
- Primary sclerosing cholangitis
- Cirrhosis
- Viral infections
- HIV
- EBV
- Hepatitis viruses
- Hepatitis B
- Hepatitis C
- Liver fluke infections
- Hepatolithiasis
- Choledochal cysts
- Infusion of certain chemical agents such as naphthenic acids
- Recurrent pyogenic cholangitis
- Opisthorchis viverrini
- Clonorchis sinensis
- Caroli's disease
- Inherited disorders
- Lynch syndrome
- Biliary papillomatosis
References
- ↑ Al-Bahrani R, Abuetabh Y, Zeitouni N, Sergi C (2013). "Cholangiocarcinoma: risk factors, environmental influences and oncogenesis". Ann. Clin. Lab. Sci. 43 (2): 195–210. PMID 23694797.
- ↑ Tyson GL, El-Serag HB (2011). "Risk factors for cholangiocarcinoma". Hepatology. 54 (1): 173–84. doi:10.1002/hep.24351. PMC 3125451. PMID 21488076.
- ↑ Ben-Menachem T (2007). "Risk factors for cholangiocarcinoma". Eur J Gastroenterol Hepatol. 19 (8): 615–7. doi:10.1097/MEG.0b013e328224b935. PMID 17625428.
- ↑ Gatto M, Alvaro D (2010). "Cholangiocarcinoma: risk factors and clinical presentation". Eur Rev Med Pharmacol Sci. 14 (4): 363–7. PMID 20496549.
- ↑ Acalovschi M (2004). "Cholangiocarcinoma: risk factors, diagnosis and management". Rom J Intern Med. 42 (1): 41–58. PMID 15529594.